Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Jonctum
2. N-acetyl Cis-4-hydroxy-l-proline
3. N-acetyl-4-hydroxyproline
4. N-acetylhydroxyproline
5. Oxaceprol, (cis)-isomer
6. Tejuntivo
1. 33996-33-7
2. N-acetyl-l-hydroxyproline
3. (2s,4r)-1-acetyl-4-hydroxypyrrolidine-2-carboxylic Acid
4. Ac-hyp-oh
5. Jonctum
6. Oxaceprol [inn]
7. L-proline, 1-acetyl-4-hydroxy-, (4r)-
8. Trans-1-acetyl-4-hydroxy-l-proline
9. N-acetyl-trans-4-hydroxy-l-proline
10. Acetyl Hydroxyproline
11. Q0xv76b96l
12. Oxaceprol (inn)
13. (-)-1-acetyl-4-hydroxy-l-proline
14. N-acetylhydroxyproline
15. Dsstox_cid_26410
16. Dsstox_rid_81589
17. Dsstox_gsid_46410
18. Oxaceprolum
19. Tejuntivo
20. Mfcd00037339
21. Smr000857165
22. Cas-33996-33-7
23. Oxaceprolum [inn-latin]
24. Unii-q0xv76b96l
25. Ahp 200
26. Ncgc00164517-01
27. Einecs 251-780-6
28. Jonctum (tn)
29. (4r)-1-acetyl-4-hydroxy-l-proline
30. Oxaceprol [mi]
31. Acetyl-l-4-hydroxyproline
32. Oxaceprol [mart.]
33. Oxaceprol [who-dd]
34. Schembl25976
35. Mls001332445
36. Mls001332446
37. Chembl1407356
38. Dtxsid2046410
39. Hms2231j23
40. Zinc154540
41. Acetyl Hydroxyproline [inci]
42. Tox21_112152
43. Ab1252
44. Akos012536015
45. Akos015837714
46. Tox21_112152_1
47. Acetyl-4-hydroxy-l-proline, Trans-1-
48. Ccg-266379
49. Cs-5680
50. Db13363
51. Nalpha-acetyl-l-4-trans-hydroxyproline
52. Ncgc00274081-01
53. Hy-17490
54. Ts-00164
55. Db-009006
56. S3997
57. Trans-1-acetyl-4-hydroxy-l-proline, >=98%
58. D07215
59. 996a337
60. A822032
61. Q408948
62. W-106758
63. (2s)-1-acetyl-3-hydroxy-pyrrolidine-2-carboxylic Acid
64. (2s,4r)-1-acetyl-4-hydroxy-2-pyrrolidinecarboxylic Acid
65. (2s,4r)-1-acetyl-4-hydroxy-pyrrolidine-2-carboxylic Acid
66. 2235464-65-8
| Molecular Weight | 173.17 g/mol |
|---|---|
| Molecular Formula | C7H11NO4 |
| XLogP3 | -1.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 173.06880783 g/mol |
| Monoisotopic Mass | 173.06880783 g/mol |
| Topological Polar Surface Area | 77.8 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 216 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antirheumatic Agents
Drugs that are used to treat RHEUMATOID ARTHRITIS. (See all compounds classified as Antirheumatic Agents.)
Dermatologic Agents
Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)
D - Dermatologicals
D11 - Other dermatological preparations
D11A - Other dermatological preparations
D11AX - Other dermatologicals
D11AX09 - Oxaceprol
M - Musculo-skeletal system
M01 - Antiinflammatory and antirheumatic products
M01A - Antiinflammatory and antirheumatic products, non-steroids
M01AX - Other antiinflammatory and antirheumatic agents, non-steroids
M01AX24 - Oxaceprol
ABOUT THIS PAGE
A Oxaceprol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxaceprol, including repackagers and relabelers. The FDA regulates Oxaceprol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxaceprol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oxaceprol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oxaceprol supplier is an individual or a company that provides Oxaceprol active pharmaceutical ingredient (API) or Oxaceprol finished formulations upon request. The Oxaceprol suppliers may include Oxaceprol API manufacturers, exporters, distributors and traders.
click here to find a list of Oxaceprol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Oxaceprol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxaceprol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxaceprol GMP manufacturer or Oxaceprol GMP API supplier for your needs.
A Oxaceprol CoA (Certificate of Analysis) is a formal document that attests to Oxaceprol's compliance with Oxaceprol specifications and serves as a tool for batch-level quality control.
Oxaceprol CoA mostly includes findings from lab analyses of a specific batch. For each Oxaceprol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxaceprol may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxaceprol EP), Oxaceprol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxaceprol USP).
LOOKING FOR A SUPPLIER?
